Leiv Lea, Chief Financial Officer at Corvus Pharmaceuticals, Inc. (CRVS), bought 34,000 shares at $0.84 ($26K) on 2022-12-14, disclosed to the SEC on 2022-12-15.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.74 | 30,000 | $22K | 86.9% |
| 2 | $0.84 | 4,000 | $3K | 13.1% |
| Total | $0.75 avg | 34,000 | $26K | 100% |
| Filing → |
| CRVS | BUY | 2018-12-27 | $205K | — | Filing → |
| PCYC | BUY | 2007-08-22 | $4K | — | Filing → |
| PCYC | BUY | 2007-08-22 | $6K | — | Filing → |